Table 1. Baseline characteristics of the 28 subjects, and differentiated by gender and percent body fat (values are presented as mean±s.d.).

	Overall	Gender			Body fata
	All subjects (n=28)	Male (n=11)	Female (n=17)	P-value	Overweight (n=13)	Normoweight (n=15)	P-value
Age	25.9±5.4	26.7±5.4	25.4±5.8	NS	28.6±6.6	23.6±3.0	< 0.05
Weight (kg)	72.3±18.3	87.7±17.1	62.3±10.5	< 0.001	79.7±19.5	65.9±14.9	< 0.05
BMI (kg m−2)	25.1±4.5	27.4±4.8	23.6±3.7	< 0.05	27.9±4.4	22.7±3.0	< 0.001
Body fat mass (kg)	20.8±10.3	20.2±11.6	21.2±9.8	NS	29.7±8.1	13.1±3.6	< 0.001
Body fat (%)	29.6±11.0	22.8±8.5	34.0±10.8	< 0.01	39.2±7.4	21.3±6.3	< 0.001
Cholesterol (mmol l−1)
Total cholesterol	4.86±1.12	4.07±0.69	5.22±1.67	< 0.01	4.76±1.26	4.75±1.07	NS
Non-high-density lipoprotein	3.13±1.03	2.78±0.74	3.29±1.38	NS	3.23±1.21	2.94±0.85	NS
High-density lipoprotein	1.65±0.42	1.30±0.28	1.84±0.57	< 0.001	1.53±0.45	1.65±0.42	NS
Fasting plasma glucose (mmol l−1)	5.17±0.74	5.14±0.72	5.15±1.42	NS	5.44±0.93	4.94±0.40	NS
Fasting plasma insulin (μlU ml−1)	43.44±18.86	42.76±20.55	44.93±21.14	NS	49.77±19.92	40.34±18.38	NS
Inflammatory markers
IL-6 (pg ml−1) (min–max)	1.75±1.43 (0.06–5.17)	1.18±0.81 (0.33–2.59)	2.01±1.60 (0.06–5.17)	NS	2.29±1.34 (0.65–4.89)	1.28±1.33 (0.06–5.17)	NS
Hs-CRP (mg l−1) (min–max)	1.69±2.24 (0.002–7.039)	0.32±0.22 (0.052–0.805)	2.38±2.46 (0.002–7.039)	< 0.01	2.47±2.36 (0.115–6.696)	0.97±1.87 (0.002–7.039)	NS
LBP (μg ml−1) (min–max)	15.09±19.85 (0.12–88.05)	4.42±3.03 (1.00–9.61)	20.91±22.41 (0.12–88.05)	< 0.01	23.98±24.90 (2.12–88.05)	7.48±8.60 (0.12–28.51)	NS

Abbreviations: hs-CRP, high-sensitive C-reactive protein; IL, interleukin; LBP, lipopolysaccharide-binding protein; NS, not significant.

^aWomen with over 31% body fat, and men with over 25% body fat were considered as overweight individuals. All others were considered lean.